Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

Benchmarking a luciferase complementation assay for detecting protein complexes.

Cassonnet P, Rolloy C, Neveu G, Vidalain PO, Chantier T, Pellet J, Jones L, Muller M, Demeret C, Gaud G, Vuillier F, Lotteau V, Tangy F, Favre M, Jacob Y.

Nat Methods. 2011 Nov 29;8(12):990-2. doi: 10.1038/nmeth.1773. No abstract available.

PMID:
22127214
2.

Tumor suppressor or oncogene? A critical role of the human papillomavirus (HPV) E2 protein in cervical cancer progression.

Bellanger S, Tan CL, Xue YZ, Teissier S, Thierry F.

Am J Cancer Res. 2011;1(3):373-389. Epub 2011 Jan 24.

3.

Mad2 inhibits the mitotic kinesin MKlp2.

Lee SH, McCormick F, Saya H.

J Cell Biol. 2010 Dec 13;191(6):1069-77. doi: 10.1083/jcb.201003095.

4.

Cytoscape 2.8: new features for data integration and network visualization.

Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T.

Bioinformatics. 2011 Feb 1;27(3):431-2. doi: 10.1093/bioinformatics/btq675. Epub 2010 Dec 12.

5.

Manipulation of host cell death pathways during microbial infections.

Lamkanfi M, Dixit VM.

Cell Host Microbe. 2010 Jul 22;8(1):44-54. doi: 10.1016/j.chom.2010.06.007. Review.

6.

Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression.

Smith JA, White EA, Sowa ME, Powell ML, Ottinger M, Harper JW, Howley PM.

Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3752-7. doi: 10.1073/pnas.0914818107. Epub 2010 Feb 2.

7.

Cellular receptor binding and entry of human papillomavirus.

Letian T, Tianyu Z.

Virol J. 2010 Jan 6;7:2. doi: 10.1186/1743-422X-7-2. Review.

8.

ViralORFeome: an integrated database to generate a versatile collection of viral ORFs.

Pellet J, Tafforeau L, Lucas-Hourani M, Navratil V, Meyniel L, Achaz G, Guironnet-Paquet A, Aublin-Gex A, Caignard G, Cassonnet P, Chaboud A, Chantier T, Deloire A, Demeret C, Le Breton M, Neveu G, Jacotot L, Vaglio P, Delmotte S, Gautier C, Combet C, Deleage G, Favre M, Tangy F, Jacob Y, Andre P, Lotteau V, Rabourdin-Combe C, Vidalain PO.

Nucleic Acids Res. 2010 Jan;38(Database issue):D371-8. doi: 10.1093/nar/gkp1000. Epub 2009 Dec 8.

9.

Molecular mechanisms of human papillomavirus-induced carcinogenesis.

Lehoux M, D'Abramo CM, Archambault J.

Public Health Genomics. 2009;12(5-6):268-80. doi: 10.1159/000214918. Epub 2009 Aug 11. Review.

10.

Brd4 regulation of papillomavirus protein E2 stability.

Zheng G, Schweiger MR, Martinez-Noel G, Zheng L, Smith JA, Harper JW, Howley PM.

J Virol. 2009 Sep;83(17):8683-92. doi: 10.1128/JVI.00674-09. Epub 2009 Jun 24.

11.

Proteasomal degradation of the papillomavirus E2 protein is inhibited by overexpression of bromodomain-containing protein 4.

Gagnon D, Joubert S, Sénéchal H, Fradet-Turcotte A, Torre S, Archambault J.

J Virol. 2009 May;83(9):4127-39. doi: 10.1128/JVI.02468-08. Epub 2009 Feb 11.

12.

Papillomaviruses in the causation of human cancers - a brief historical account.

zur Hausen H.

Virology. 2009 Feb 20;384(2):260-5. doi: 10.1016/j.virol.2008.11.046. Epub 2009 Jan 8. Review.

13.

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.

Huang da W, Sherman BT, Lempicki RA.

Nat Protoc. 2009;4(1):44-57. doi: 10.1038/nprot.2008.211.

14.

Tax1BP1 interacts with papillomavirus E2 and regulates E2-dependent transcription and stability.

Wang X, Naidu SR, Sverdrup F, Androphy EJ.

J Virol. 2009 Mar;83(5):2274-84. doi: 10.1128/JVI.01791-08. Epub 2008 Dec 24.

15.

An empirical framework for binary interactome mapping.

Venkatesan K, Rual JF, Vazquez A, Stelzl U, Lemmens I, Hirozane-Kishikawa T, Hao T, Zenkner M, Xin X, Goh KI, Yildirim MA, Simonis N, Heinzmann K, Gebreab F, Sahalie JM, Cevik S, Simon C, de Smet AS, Dann E, Smolyar A, Vinayagam A, Yu H, Szeto D, Borick H, Dricot A, Klitgord N, Murray RR, Lin C, Lalowski M, Timm J, Rau K, Boone C, Braun P, Cusick ME, Roth FP, Hill DE, Tavernier J, Wanker EE, Barabási AL, Vidal M.

Nat Methods. 2009 Jan;6(1):83-90. doi: 10.1038/nmeth.1280. Epub 2008 Dec 7.

16.

An experimentally derived confidence score for binary protein-protein interactions.

Braun P, Tasan M, Dreze M, Barrios-Rodiles M, Lemmens I, Yu H, Sahalie JM, Murray RR, Roncari L, de Smet AS, Venkatesan K, Rual JF, Vandenhaute J, Cusick ME, Pawson T, Hill DE, Tavernier J, Wrana JL, Roth FP, Vidal M.

Nat Methods. 2009 Jan;6(1):91-7. doi: 10.1038/nmeth.1281. Epub 2008 Dec 7.

17.

Hepatitis C virus infection protein network.

de Chassey B, Navratil V, Tafforeau L, Hiet MS, Aublin-Gex A, Agaugué S, Meiffren G, Pradezynski F, Faria BF, Chantier T, Le Breton M, Pellet J, Davoust N, Mangeot PE, Chaboud A, Penin F, Jacob Y, Vidalain PO, Vidal M, André P, Rabourdin-Combe C, Lotteau V.

Mol Syst Biol. 2008;4:230. doi: 10.1038/msb.2008.66. Epub 2008 Nov 4.

18.

VirHostNet: a knowledge base for the management and the analysis of proteome-wide virus-host interaction networks.

Navratil V, de Chassey B, Meyniel L, Delmotte S, Gautier C, André P, Lotteau V, Rabourdin-Combe C.

Nucleic Acids Res. 2009 Jan;37(Database issue):D661-8. doi: 10.1093/nar/gkn794. Epub 2008 Nov 4.

19.

Direct activation of caspase 8 by the proapoptotic E2 protein of HPV18 independent of adaptor proteins.

Thierry F, Demeret C.

Cell Death Differ. 2008 Sep;15(9):1356-63. doi: 10.1038/cdd.2008.53. Epub 2008 Apr 18.

20.

The human papillomavirus type 8 E2 protein induces skin tumors in transgenic mice.

Pfefferle R, Marcuzzi GP, Akgül B, Kasper HU, Schulze F, Haase I, Wickenhauser C, Pfister H.

J Invest Dermatol. 2008 Sep;128(9):2310-5. doi: 10.1038/jid.2008.73. Epub 2008 Apr 10.

Supplemental Content

Support Center